Claire Gelfman, PhD

Dr. Gelfman received her undergraduate degree in biology at Washington University in St. Louis, Missouri and a Ph.D. in biochemistry at the University of Texas at Austin. Following a postdoctoral fellowship at the University of California at Davis, she held various research and development positions in academia and industry at the cross-section of ophthalmology and molecular genetics. Dr. Gelfman brings over 20 years of experience in drug discovery and development, and gene therapy approaches in both biotechnology companies and contract research organizations. Prior to joining the Foundation, she served as vice president, pharmaceutical development at Adverum Biotechnologies, Inc. in California.